Colorcon delivers savings, speed and flexibility for pharmaceutical film coating with Opadry QX
The system can be applied over a broad range of process conditions, including those containing temperature-sensitive active ingredients.
Colorcon Inc. is excited to announce an innovative breakthrough for pharmaceutical tablet coating, with the launch of Opadry QX, quick and fleXible film coating. This revolutionary advance greatly reduces production and preparation times, ensuring coating process efficiency and cost savings in all types of equipment, from traditional pans to continuous coating equipment. The system can be applied over a broad range of process conditions and always results in a premium quality finish for tablets, even those containing temperature-sensitive active ingredients.
Jason Teckoe, Senior Manager – Product Development explains: “Colorcon carried out extensive studies that clearly demonstrate the process adaptability of Opadry QX. The results confirm that Opadry QX provides operators with broader latitude to manage critical settings for optimal film coating such as tablet bed temperatures, spray or air flow rates.”
Latest innovation enables rapid build-up for international manufacturing
Kelly Boyer, General Manager, Film Coatings at Colorcon Inc. further notes: “The commercial impact of the process and equipment flexibility offered by Opadry QX means that multinational pharmaceutical companies can easily transition the manufacture of drug products across continents, overcoming challenges often met with equipment differences. Capital investment may also be deferred through more efficient equipment utilization as productivity demand increases."
This latest innovation clearly demonstrates Colorcon’s leadership in bringing to market film coating systems with enhanced functionality along with improved convenience, manufacturing efficiency, cost savings and dependable performance for the pharmaceutical industry.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
.png)
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
.png)
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
.png)
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
.png)
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance